The Medicine for Good Podcast, hosted by Dr. Julieta Gabiola, gives a human face to medical science and explores the lives of clinicians and the people they serve and touch.
It will help translate scientific and technological discoveries and innovations into what really matters, expanding our understanding of medical philanthropy, volunteerism, and altruism.
Medicine For Good is a 30min podcast focusing the first 5-10 minutes is an introduction of the episode with the latest information on the topic and how it effects our lives.
This will be followed by a 20minute conversation with experts on the topic and their practice experiences.
We hope you enjoy our podcast as we explore humanity beyond the white coat.
Hosted on Acast. See acast.com/privacy for more information.
The Medicine for Good Podcast, hosted by Dr. Julieta Gabiola, gives a human face to medical science and explores the lives of clinicians and the people they serve and touch.
It will help translate scientific and technological discoveries and innovations into what really matters, expanding our understanding of medical philanthropy, volunteerism, and altruism.
Medicine For Good is a 30min podcast focusing the first 5-10 minutes is an introduction of the episode with the latest information on the topic and how it effects our lives.
This will be followed by a 20minute conversation with experts on the topic and their practice experiences.
We hope you enjoy our podcast as we explore humanity beyond the white coat.
Hosted on Acast. See acast.com/privacy for more information.
What if a simple blood test could detect cancer early enough to save lives?
In today’s Medicine for Good episode, Beyond the Signal, we delve into the inspiring and hopeful story of Roger Royse, a Silicon Valley startup lawyer diagnosed with stage 2 pancreatic cancer. Unlike many others, Roger’s cancer was detected early thanks to a groundbreaking Multi-Cancer Early Detection (MCED) blood test, Galleri by GRAIL. While 70% of cancers do not have standard screening options, Roger's proactive approach highlights the power of these new diagnostic tools, particularly for elusive cancers like pancreatic cancer, which often go undetected until it's too late.
Roger shares his emotional journey—from the initial shock of the diagnosis to his aggressive chemotherapy regimen and the experimental cancer vaccine that led him to remission. His resilience is evident as he recounts his determination to seek out life-saving technologies, even when faced with medical roadblocks.
Despite having no symptoms, Roger's decision to pursue the MCED test was pivotal in catching the disease early. He challenges the outdated notion that cancer screening should only be done when symptoms arise.
In this episode, we also touch on the broader implications of multi-cancer detection technology. Early detection through blood tests could revolutionize cancer care, reducing late-stage diagnoses and improving patient outcomes. Roger’s story isn’t just about survival—it’s about advocacy. He’s now using his platform to promote the importance of being proactive about health, even when you feel healthy. For him, the key takeaway is clear: Early detection saves lives.
Join us as we explore the future of cancer detection, the human side of a high-tech medical breakthrough, and how a simple blood test gave Roger a second chance at life.
Mentioned in the Show:
About the Host:
Dr. Jette is a Clinical Professor of Medicine at Stanford University and the President & CEO of ABCs for Global Health. Click here for her full profile or read her full interview here.
Hosted on Acast. See acast.com/privacy for more information.